Close Menu

NEW YORK (GenomeWeb) – Luminex announced this morning that it expects to report fourth quarter revenues of approximately $81 million, which would represent roughly 4 percent growth over the $78.2 million it reported for Q4 2017.

The estimate would beat Wall Street's average estimate for revenues of $78 million for the fourth quarter of 2018.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.